Posted by Michael Wonder on 25 Jul 2016
TGA publishes AusPAR for adalimumab (Humira)
25 July 2016 - The TGA has published an AusPAR for AbbVie's Humira.
The TGA approved adalimumab on 6 April 2016 for the treatment of moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.
